Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Острая боль в горле
Острая боль в горле
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Tiemstra J et al. Role of Non-Group A Streptococci in Acute Pharyngitis. JABFM 2009; 22 (6): 663–9.
2. Graham Worrall Acute Sore throat. Can Fam Physician 2011; 57: 792–4.
3. Regoli M et al. Update of the management of acute pharyngitis in children. Ital Pediatr 2011; 37: 10.
4. Покровский В.И. Стрептококки и стрептококкозы. М.: ГЭОТАР-Медиа, 2006.
5. Ovetchkine P. Acute tonsillitis: towards a new therapeutic strategy. Arch Pediatr 1998; 5 (6): 679–80.
6. Pessey JJ. Inflammation and acute pharyngo-tonsillitis. Presse Med 2001; 30 (39–40 Pt 2): 55–63.
7. Centor R. Witherspoon J, Dalton H et al. The diagnosis of strep throat in adults in the emergency room. Med Decis Mak 1981; 1 (3): 239–46.
8. Singh S. Optimal management of adults with pharyngitis – a multi-criteria decision analysis. BMC Med Inform Decis Mak 2006; 13 (3): 6–14.
9. Lindbaek M. Clinical symptoms and signs in sore throat patients with large colony variant beta-haemolytic streptococci groups C or G versus group A. Br J Gen Pract 2005; 55 (517): 615–9.
10. Cooper RJ. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Emerg Med 2001; 37 (6): 711–9.
11. Страчунский Л.С. Влияние антибиотикорезистентности на выбор антимикробных препаратов в оториноларингологии. Журн. ушных, носовых и горловых болезней. 2002; 5: 83–91.
12. Pichichero ME. Group A beta-hemolytic streptococcal infections. Pediatr Rev 1998; 19 (9): 291–302.
13. Jeffrey A et al. Antibiotic treatment of adults with sore throat by community primary care physicians. JAMA 2001; 286 (10): 1181–6.
14. Thomas M et al. How effective are treatments other than antibiotics for acute sore throat? B J Gen Pract 2000; 50: 817–20.
15. Watson N, Nimmo WS, Christian J et al. Relief of sore throat with the anti-inflammatory throat lozenge flurbiprofen 8.75 mg: a randomised, double-blind, placebo-controlled study of efficacy and safety. Int J Clin Pract 2000; 54 (8): 490–6.
16. Blagden M, Christian J, Miller K, Charlesworth A. Multidose flurbiprofen 8.75 mg lozenges in the treatment of sore throat: a randomised, double-blind, placebo-controlled study in UK general practice centres. Int J Clin Pract 2002; 56 (2): 95–100.
17. Benzimoj SI, Langford JH, Christian J et al. Efficacy and tolerability of the anti-inflammatory throat lozenge Flurbiprofen 8.75 mg in the treatment of sore throat. Clin Drug Invest 2001; 21 (3): 183–93.
18. Schachtel BP, Homan HD, Gibb IA, Christian J. Demonstration of dose response of flurbiprofen lozenges with the sore throat pain model. Clin Pharmacol Ther 2002; 71 (5): 375–80.
19. Butler CC, Rollnick S, Kinnersley P et al. Reducing antibiotics for respiratory tract symptoms in primary care: consolidating “why” and considering “how”. Br J Gen Pract 1998; 48 (437): 1865–70.
2. Graham Worrall Acute Sore throat. Can Fam Physician 2011; 57: 792–4.
3. Regoli M et al. Update of the management of acute pharyngitis in children. Ital Pediatr 2011; 37: 10.
4. Покровский В.И. Стрептококки и стрептококкозы. М.: ГЭОТАР-Медиа, 2006.
5. Ovetchkine P. Acute tonsillitis: towards a new therapeutic strategy. Arch Pediatr 1998; 5 (6): 679–80.
6. Pessey JJ. Inflammation and acute pharyngo-tonsillitis. Presse Med 2001; 30 (39–40 Pt 2): 55–63.
7. Centor R. Witherspoon J, Dalton H et al. The diagnosis of strep throat in adults in the emergency room. Med Decis Mak 1981; 1 (3): 239–46.
8. Singh S. Optimal management of adults with pharyngitis – a multi-criteria decision analysis. BMC Med Inform Decis Mak 2006; 13 (3): 6–14.
9. Lindbaek M. Clinical symptoms and signs in sore throat patients with large colony variant beta-haemolytic streptococci groups C or G versus group A. Br J Gen Pract 2005; 55 (517): 615–9.
10. Cooper RJ. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Emerg Med 2001; 37 (6): 711–9.
11. Страчунский Л.С. Влияние антибиотикорезистентности на выбор антимикробных препаратов в оториноларингологии. Журн. ушных, носовых и горловых болезней. 2002; 5: 83–91.
12. Pichichero ME. Group A beta-hemolytic streptococcal infections. Pediatr Rev 1998; 19 (9): 291–302.
13. Jeffrey A et al. Antibiotic treatment of adults with sore throat by community primary care physicians. JAMA 2001; 286 (10): 1181–6.
14. Thomas M et al. How effective are treatments other than antibiotics for acute sore throat? B J Gen Pract 2000; 50: 817–20.
15. Watson N, Nimmo WS, Christian J et al. Relief of sore throat with the anti-inflammatory throat lozenge flurbiprofen 8.75 mg: a randomised, double-blind, placebo-controlled study of efficacy and safety. Int J Clin Pract 2000; 54 (8): 490–6.
16. Blagden M, Christian J, Miller K, Charlesworth A. Multidose flurbiprofen 8.75 mg lozenges in the treatment of sore throat: a randomised, double-blind, placebo-controlled study in UK general practice centres. Int J Clin Pract 2002; 56 (2): 95–100.
17. Benzimoj SI, Langford JH, Christian J et al. Efficacy and tolerability of the anti-inflammatory throat lozenge Flurbiprofen 8.75 mg in the treatment of sore throat. Clin Drug Invest 2001; 21 (3): 183–93.
18. Schachtel BP, Homan HD, Gibb IA, Christian J. Demonstration of dose response of flurbiprofen lozenges with the sore throat pain model. Clin Pharmacol Ther 2002; 71 (5): 375–80.
19. Butler CC, Rollnick S, Kinnersley P et al. Reducing antibiotics for respiratory tract symptoms in primary care: consolidating “why” and considering “how”. Br J Gen Pract 1998; 48 (437): 1865–70.
Авторы
Г.С.Мальцева
ФГБУ Санкт-Петербургский научно-исследовательский институт уха, горла, носа и речи Минздравсоцразвития РФ
ФГБУ Санкт-Петербургский научно-исследовательский институт уха, горла, носа и речи Минздравсоцразвития РФ
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.